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Summary
 
An important checkpoint in early thymocyte development ensures that only thymocytes with
an in-frame T cell receptor for antigen 
 
b
 
 (TCR-
 
b
 
) gene rearrangement will continue to ma-
ture. Proper assembly of the TCR-
 
b
 
 chain into the pre-TCR complex delivers signals through
 
the 
 
src
 
-family protein tyrosine kinase p56
 
lck
 
 that stimulate thymocyte proliferation and differen-
tiation to the CD4
 
1
 
CD8
 
1
 
 stage. However, the biochemical mechanisms governing p56
 
lck
 
 acti-
vation remain poorly understood. In more mature thymocytes, p56
 
lck
 
 is associated with the cy-
toplasmic domain of the TCR coreceptors CD4 and CD8, and cross-linking of CD4 leads to
p56
 
lck
 
 activation. To study the effect of synchronously inducing p56
 
lck
 
 activation in immature
CD4
 
2
 
CD8
 
2
 
 thymocytes, we generated mice expressing a CD4 transgene in Rag2
 
2/2
 
 thy-
mocytes. Remarkably, without further experimental manipulation, the CD4 transgene drives
maturation of Rag2
 
2/2
 
 thymocytes in vivo. We show that this process is dependent upon the
ability of the CD4 transgene to bind Lck and on the expression of MHC class II molecules.
Together these results indicate that binding of MHC class II molecules to CD4 can deliver a
biologically relevant, Lck-dependent activation signal to thymocytes in the absence of the
TCR-
 
a
 
 or -
 
b
 
 chain.
 
I
 
n mammals, circulating T lymphocytes derive from bone
marrow progenitors that mature within the thymus. This
maturation process involves both replicative expansion and
differentiation, and yields progeny cells expressing a diverse
repertoire of clonally-distributed TCRs specific for anti-
genic peptides bound to MHC molecules. Signals derived
from non-receptor protein tyrosine kinases direct the highly-
regulated development of thymocyte progenitors (1), which
can only take place in close approximation with thymic stro-
mal elements (2).
Immature hematopoietic progenitors arriving in the thy-
mus contain TCR genes in germline configuration, lack
both CD4 and CD8 on their cell surfaces, and express only
very low levels of the TCR-associated CD3
 
g
 
, 
 
d
 
, and 
 
e
 
polypeptides. Thereafter, in-frame gene rearrangement at
the TCR-
 
b
 
 locus leads to expression of a functional TCR-
 
b
 
polypeptide, which is presented at the cell surface in associ-
ation with the recently described pT
 
a
 
 chain (3) and the
CD3
 
g
 
, 
 
d
 
, and 
 
e
 
 molecules (4, 5). This complex, known as
the pre-T cell receptor (pre-TCR), delivers signals that
block further rearrangements at the TCR-
 
b
 
 locus, while
stimulating both proliferation and the onset of rearrange-
ments at the complementary TCR-
 
a
 
 locus (6–8). In addi-
tion, the pre-TCR-derived signal leads to simultaneous ex-
pression of CD4 and CD8 on the surfaces of developing
thymocytes. Subsequent gene rearrangement at the TCR-
 
a
 
locus permits assembly of the mature 
 
ab
 
 TCR, which can
thereafter deliver signals that trigger the differentiation of
functional T lymphocytes, cells which express either CD4
or CD8 in a mutually exclusive fashion (9).
The signaling circuits that link the pre-TCR to appro-
priate cellular responses remain incompletely elucidated.
However, experiments in genetically manipulated mice
strongly implicate the 
 
src-
 
family protein tyrosine kinase
p56
 
lck
 
 in the pre-TCR signal transduction pathway (10). In
thymocytes from mice lacking expression of CD3
 
e
 
 (11),
pT
 
a
 
 (12), or TCR-
 
b
 
 (7), failure to assemble the pre-TCR
results in arrested thymocyte development at a very imma-
ture CD4
 
2
 
8
 
2
 
 (double-negative or DN
 
1
 
) stage. An analo-
gous phenotype obtains in thymocytes of transgenic mice
expressing high levels of a catalytically inactive Lck protein
(13) and in mice bearing a targeted disruption of the 
 
lck
 
gene (14), although some thymocyte differentiation does
 
1
 
Abbreviations used in this paper:
 
 DN, double-negative; DP, double-posi-
tive; ITAM, immunoreceptor tyrosine-based activation motifs.
  
122
 
CD4 Behaves as an MHC Class II-responsive Signaling Element
 
occur in the latter, likely reflecting the ability of other, re-
lated kinases to substitute in the absence of Lck (15, 16).
Importantly, expression of a mutant, activated Lck kinase is
sufficient, by itself, to drive both the proliferative expan-
sion and the differentiation of thymocytes made incapable
of expressing the pre-TCR. For example, an activated-
 
lck
 
transgene drives thymocyte development in Rag
 
2/2
 
 thy-
mocytes, which cannot rearrange their TCR gene loci and
therefore fail to make a TCR-
 
b
 
 chain (17). Together these
experiments strongly support a model in which assembly of
the pre-TCR permits, either through binding of an exter-
nal ligand or through some allosteric alteration, the activa-
tion of p56
 
lck
 
, which then directs thymocyte maturation to
the CD4
 
1
 
8
 
1
 
 (double-positive or DP) stage.
While the genetic evidence favoring a role for Lck in
signaling from the pre-TCR is persuasive, the biochemical
effectors upon which Lck acts, as well as the mechanisms of
Lck activation, remain unknown. In more mature thy-
mocytes and T cells, p56
 
lck
 
 interacts physically and func-
tionally with the TCR coreceptors, CD4 and CD8, by vir-
tue of a sequence motif centered around cysteines 20 and
23 that binds a complementary motif in the cytoplasmic
tails of CD4 and CD8 (18). Contemporary models of TCR
signaling posit that CD4 and CD8 act to deliver Lck to the
antigen receptor complex at the time of ligand binding, per-
mitting activation of Lck, which then acts to phosphorylate
specialized tyrosine-containing motifs (ITAMs) in the CD3
 
g
 
,
 
d
 
, and 
 
e
 
 chains and in the TCR 
 
z
 
 polypeptides, the latter
found principally as homodimers associated with the TCR
complex (19). This phosphorylation permits binding of the
Zap-70 protein tyrosine kinase to the phosphorylated ITAMs,
where it too becomes a target for Lck-mediated phosphor-
ylation (19, 20). Interestingly, antibody-mediated cross-link-
ing of CD4 stimulates Lck kinase activity in murine thy-
mocytes (21) and T cell clones (22), suggesting that binding
of CD4 to MHC class II polypeptides under physiologic
conditions may, by itself, stimulate Lck activity.
Dissection of the biochemical pathways linking Lck to
changes in thymocyte maturation requires a means of di-
rectly stimulating Lck activity in vivo. Here we report that
expression of a CD4 transgene in Rag2
 
2/2
 
 mice has this ef-
fect, directing thymocyte development in a manner that
mimics signaling from the pre-TCR. Remarkably, this
process is dependent upon the expression of MHC class II
molecules, and hence represents a ligand-stimulated signal-
ing process mediated by CD4. While our experiments
leave no doubt as to the ability of CD4 to behave as a re-
ceptor in its own right, we also demonstrate that faithful
delivery of the CD4/Lck-derived signal requires the simul-
taneous presence of CD3 components of the pre-TCR
complex.
 
Materials and Methods
 
Mice.
 
All Rag2
 
2/2
 
 mice were housed in a specific pathogen-
free (SPF) facility and analyzed at 3–6 wk of age. Transgenic lines
were derived by microinjection into DBA/2
 
 3 
 
C57BL6/J zy-
gotes as described (23). The 727 CD4 transgenic mouse line has
previously been described (24). A single line of mice transgenic
for tailless CD4 was generated using the previously described
construct (25). Transgene-bearing mice for each of these lines
were mated with Rag2
 
2/2
 
 mice (26), and their progeny inter-
crossed to obtain transgene expression in homozygous Rag2
 
2/2
 
mice. CD4Tg
 
1
 
 (CD4 transgenic) Rag2
 
2/2
 
 mice were further
crossed with MHC class II
 
2/2
 
 mice (27). CD4Tg
 
1
 
 mice were also
crossed with CD3
 
e
 
2/2
 
 mice (11). PCR analysis was employed to
detect the presence of the transgenes using the following pairs of
forward and reverse primers:
CD4 and tailless CD4 (CD4
 
D
 
) transgenes:
5
 
9
 
 GTCAGGAGCTTGAATCCCACGATTCGGGGATCA-
TCTAGAC 3
 
9
 
 (specific for the junction of proximal 
 
lck
 
 promoter
sequences with polylinker sequence in the 
 
lck
 
-CD4 transgene
[24])
5
 
9
 
 CCACAACTCCACCTCCTCTTTCCT 3
 
9
 
 (correspond-
ing to nucleotides 518-541 of the murine CD4 cDNA [28])
Rag2:
5
 
9
 
 CCAGCTGATAACCACCCACAATAA 3
 
9
 
5
 
9
 
 GTATAGTCGAGGGAAAAGCATGGG 3
 
9
 
Neomycin cassette in gene targeting constructs:
5
 
9
 
 CAGGATCTCCTGTCATCTCACCTT 3
 
9
 
5
 
9
 
 TCAGAAGAACTCGTCAAGAAGGCG 3
 
9
 
I-A
 
b
 
 endogenous locus:
5
 
9
 
 CATTTCGTGTACCAGTTCATGGGC 3
 
9
 
5
 
9
 
 CTCGTAGTTGTGTCTGCACACCGTGTC 3
 
9
 
I-A
 
b
 
 gene targeting construct:
5
 
9
 
 TACATCTACAACCGGGAGGAGTAC 3
 
9
 
Neomycin cassette forward primer
CD3
 
e
 
:
5
 
9
 
 TCAGGAACCAGTGTAGAGTTGACG 3
 
9
 
5
 
9
 
 GTCCACCTCCACACAGTACTCACA 3
 
Flow Cytometric Analysis.
 
Isolated thymocytes were prepared
by disaggregation through a wire mesh, and stained with saturat-
ing levels of mAb at 4
 
8
 
C in 1% FCS in PBS. Cells were counted
using a hemocytometer and 
 
z
 
10
 
6
 
 thymocytes were stained with
combinations of the following murine-specific mAb: Anti-CD4
PE (CT-CD4) and anti-CD8
 
a
 
 (CT-CD8
 
a
 
) from Caltag Labora-
tories (San Francisco, CA); anti-CD25PE (M-A251), anti-CD8
 
a
 
PE (53-6.7), biotinylated anti-I-A
 
b
 
 (AF6-120.1), biotinylated
anti-CD3
 
e
 
 (145-2C11), and biotinylated anti-CD69 (H1.2F3)
from PharMingen (San Diego, CA). For detection of biotinylated
reagents, cells were further stained with tri-color conjugated strep-
tavidin (Caltag Laboratories). After staining, cells were fixed in 2%
paraformaldehyde, pH 7.4. 20,000 live lymphocyte-gated events
were collected for each analysis in list mode files on a FACScanÒ
flow cytometer (Becton Dickinson) using Cell Quest software,
and analyzed using Reproman software (Truefacts Software, Seat-
tle, WA).
Antibody Treatment of Mice. 4-wk-old mice were injected in-
traperitoneally with 100 mg of anti-CD3e (145-2C11), or 20-500 mg
of anti-CD4 mAb (GK1.5) diluted in 300 ml of PBS. The mAb
were affinity-purified on protein A or G Sepharose, respectively.
Mice were typically analyzed 4 d after mAb treatment. CD69 in-
duction was measured 20 h after intraperitoneal injection of 150 mg
of 145-2C11 or GK1.5 mAb.
Results
CD4 Transgene Promotes Thymocyte Development in Rag22/2
Mice. To determine whether we could effect CD4-medi-
ated p56lck activation in pre-T cells in vivo, a CD4 mini-123 Norment et al.
types associated with the DN to DP transition in normal
thymocytes (8). Together these results indicate that the
simple expression of CD4 (albeit at high levels) in the DN
compartment faithfully reproduces signals ordinarily associ-
ated with satisfactory assembly of the pre-TCR. This oc-
curred without any measurable change in the surface repre-
sentation of CD3 components (judged by flow cytometric
analysis of CD3e expression), and hence suggests that the
presence of transgene-derived CD4 was directly responsi-
ble for this phenomenon.
CD4 Transgene-driven Maturation Requires the Lck-Interact-
ing Region. Because activated Lck (containing a phenylal-
anine-for-tyrosine substitution at position 505) can stimu-
late the DN to DP transition in Rag2/2 thymocytes (17),
and because Lck binds directly to CD4 (18), we reasoned
that expression of transgene-derived CD4 in Rag22/2 thy-
mocytes had permitted assembly of a signaling complex
leading to Lck activation in vivo. This hypothesis predicts
that the ability of CD4 to stimulate thymocyte develop-
ment would depend upon its interaction with Lck. To test
this conjecture, we generated an additional line of trans-
genic animals expressing a mutant CD4 transgene (CD4D)
in which sequences encoding all but the eight most mem-
brane-proximal cytoplasmic residues were truncated. Prior
studies have demonstrated that this truncation yields a mol-
ecule that cannot interact with p56lck (25). Fig. 2 A shows
that although the CD4D transgene was expressed under
the lck proximal promoter at levels comparable to those
achieved using the wild-type CD4 transgene, Rag22/2 thy-
mocytes were not induced to mature by the presence of
this mutant protein. Indeed, even when the CD4D trans-
genic mice were intercrossed in the effort to obtain prog-
eny with increased expression of truncated CD4, no im-
provement in thymocyte maturation was noted (Fig. 2 B).
We conclude that the CD4 cytoplasmic tail, almost cer-
tainly reflecting its ability to bind p56lck, is required to per-
mit a CD4-derived signal to drive the DN to DP transition
in thymocytes.
CD4 Transgene-driven Maturation Requires Expression of
MHC Class II Molecules. We next asked whether the pres-
ence of CD4 in immature thymocytes was by itself suffi-
cient to stimulate maturation, or whether interaction with
an MHC class II ligand was required. The extracellular do-
main of CD4 binds directly to the MHC class II b2 domain
(29, 30), and it is well established that CD4 coreceptor
function requires MHC class II binding in mature T cells
(31). To determine whether CD4 transgene-driven thy-
mocyte maturation in Rag22/2 mice is dependent upon
MHC class II molecules, CD4Tg1 Rag22/2 mice were
crossed with MHC class II2/2 mice (generated through tar-
geted disruption of the I-Ab locus [27]). Rag22/2, CD4Tg,
and MHC class II2/2 mice share the H-2b haplotype, and
therefore lack surface expression of MHC class II I-E pro-
teins due to a pre-existing mutation in the Ea gene pro-
moter (32). As shown in Fig. 3 A, in the absence of MHC
class II expression (right panel), the CD4 transgene no
longer stimulates the acquisition of CD8 expression in
Rag22/2 thymocytes. Indeed, in CD4Tg mice made simul-
Figure 1. Flow cytometric analysis of thymocytes from Rag22/2 and
CD4 transgenic Rag22/2 mice. Two parameter fluorescence histograms
of lymphocyte gated events are shown after cell surface staining of thy-
mocytes from age matched mice with anti-CD4-PE and anti-CD8-FITC
(top), or anti-CD8-PE and anti-CD25-FITC (middle). Forward light scat-
ter profiles (FSC) are also shown (bottom) as an indication of relative cell
size. The percentage of cells in each population is indicated. Under iden-
tical staining conditions, wild-type CD41 thymocytes lie at z100 units
on the logarithmic scale.
gene under the control of the lck proximal promoter (24)
was placed on a Rag22/2 background. By flow cytometry,
CD4Tg1 Rag22/2 thymocytes express z10-fold higher
levels of CD4 on their surfaces as compared with those
found on more mature, wild-type CD41 thymocytes (Fig. 1).
An effect of the CD4 transgene was readily apparent: thy-
muses from the CD4 transgenic animals were larger than
those of Rag22/2 littermate controls, and showed a fivefold
increase in cell number (z1 3 107 vs. z2 3 106 thy-
mocytes in Rag22/2 mice). Remarkably, the majority of
thymocytes in CD4Tg-bearing Rag22/2 mice acquired
surface expression of endogenously encoded CD8 (Fig. 1,
top). These cells also lost expression of CD25 (Fig. 1, mid-
dle), and were smaller in size (Fig. 1, bottom), both pheno-124 CD4 Behaves as an MHC Class II-responsive Signaling Element
taneously null for Rag2 and heterozygous for the disrupted
I-Ab allele, the representation of DP cells typically reached
only 40% of that observed in those bearing two wild-type
I-Ab alleles (Fig. 3 A, middle panels and B). Hence the ac-
tual dose of MHC class II molecules available to bind CD4
appears to regulate propagation of a differentiative signal.
In accord with this observation, the amount of stainable
MHC class II protein on the surfaces of thymocytes was
greatly increased by the presence of transgene-derived CD4
(Fig. 3 A, bottom). Thymocytes transgenic for the CD4D
construct also showed increased staining for I-Ab (data not
shown). Passive adsorption of shed class II molecules onto
normal thymocytes has been previously demonstrated using
allogeneic bone marrow chimeras (33). The increased I-Ab
staining on CD4 transgenic thymocytes almost certainly re-
flects direct binding of shed class II molecules to this trans-
gene-encoded class II receptor, supporting the notion that
CD4 delivers an Lck activation signal in Rag22/2 thy-
mocytes in response to binding of the agonist ligand, I-Ab.
Murine thymocytes themselves do not synthesize signifi-
cant amounts of MHC class II molecules (33, 34). 
Previous studies demonstrate that administration of anti-
CD3 antibodies to Rag22/2 mice stimulates the DN to DP
transition, an effect which depends upon the presence of
Lck (35). Because administration of anti-CD4 antibodies to
T cell clones (22) as well as murine thymocytes (21) stimu-
lates Lck activity, and because expression of MHC class II
molecules stimulates CD4-driven thymocyte maturation in
Rag22/2 mice, we wished to determine whether anti-CD4
mAb treatment would similarly drive maturation of CD4Tg1
Rag22/2 MHC class II2/2 thymocytes. Fig. 4 A demon-
strates that anti-CD3 treatment effectively stimulates thy-
mocyte maturation in Rag22/2 MHC class II2/2 mice, irre-
spective of the presence of the CD4 transgene. In contrast,
administration of the anti-CD4 mAb GK1.5 did not stimu-
late maturation of CD4Tg-bearing thymocytes. However,
all CD4Tg1 Rag22/2 MHC class II2/2 thymocytes clearly
are capable of receiving a GK1.5 stimulated signal: GK1.5
or anti-CD3 induce comparable surface expression of the
activation marker CD69 (36) within 24 h of mAb treat-
ment (Fig. 4 B). CD69 expression is believed to increase after
receipt of normal pre-TCR signals (35). Moreover, anti-
Figure 2. Flow cytometric analysis of thymocytes from wild-type CD4Tg1 Rag22/2 and tailless CD4D Rag22/2 transgenic mice. (A) Representative
fluorescence staining profiles of CD4 and CD8 are shown for thymocytes from age matched CD4Tg1 Rag22/2 mice (CD4, left panel) or tailless CD4
(CD4D, middle panel) Rag22/2 mice (n 5 6). A single parameter histogram better shows the relative levels of CD4 expression (right panel) for these mice
as compared to a transgene negative littermate control of CD4D (Neg. Cont.). (B) A similar immunofluorescense analysis is shown for thymocytes from a
CD4Tg1 Rag22/2 mouse (left panel), and two of seven CD4D Rag22/2 positive progeny from a CD4D 3 CD4D mating (middle two panels). Two param-
eter fluorescence profiles are shown for wild-type CD4Tg1 and the mice expressing the lowest (CD4Dlo) and highest (CD4Dhi) level of CD4D in the lit-
ter. The relative levels of CD4 expression are again shown by a single parameter histogram (right panel). The percentage of cells in each population is in-
dicated. While some CD4D Rag22/2 mice (7/21 analyzed) contained a very small fraction of CD81CD252 thymocytes (1–2%), this did not correlate
with the level of CD4D expression. The relative percentage of CD81CD252 thymocytes in wild-type CD4 Rag 22/2/CD4D Rag 22/2 mice was .50-
fold.125 Norment et al.
CD3-stimulated CD69 induction is impaired in Lck2/2
mice (35). Hence treatment with anti-CD4 mAb delivers a
signal to CD4Tg1 Rag22/2 MHC class II2/2 thymocytes
that recapitulates one feature of the Lck-dependent pre-
TCR signaling process. This signal may differ qualitatively
or quantitatively from that which devolves after interaction
of CD4 with class II molecules (see below). 
CD4 Transgene-driven Maturation Requires Expression of
CD3 Chains. Maturation of DN thymocytes ordinarily
requires assembly of the pre-TCR complex (6), which is
composed of the CD3 chains, the pTa polypeptide, and the
TCR-b chain (5, 7, 10–12). Although the CD4/class II inter-
action in our transgenic animals mimics pre-TCR signaling
in Rag22/2 thymocytes (in the absence of a TCR-b chain),
it remained plausible that other pre-TCR components, no-
tably the CD3 polypeptides, might be necessary to permit
delivery of an Lck-derived signal. To investigate the signal-
ing requirements in this system, we introduced the CD4
transgene into a CD3e2/2 background. As in Rag22/2 mice,
thymocytes of CD3e2/2 mice do not mature beyond the
DN stage (11). These thymocytes also contain greatly re-
duced levels of the CD3g and CD3d transcripts, an effect
Figure 3. Flow cytometric analysis of thymocytes from CD4Tg1 Rag22/2
mice mated onto an MHC class II2/2 background. (A) Fluorescence staining pro-
files of CD4 and CD8 (top panels) or the MHC class II molecule I-Ab (bottom panels)
of thymocytes from a CD4 transgene negative MHC class II wild-type control
(Rag22/2 MHC II1/1) and CD4 transgene positive littermates that are wild-type
(CD4Tg1 Rag22/2 MHC II1/1), heterozygous (CD4Tg1 Rag22/2 MHC II1/2) or
null (CD4Tg1 Rag22/2 MHC II2/2) for MHC class II expression. The percentage
of cells in each population is indicated. Unlike thymi from CD4Tg1 Rag22/2
mice that were first analyzed (Fig. 1), thymi from the crosses of CD4Tg1 Rag22/2
mice with MHC class II2/2 mice did not exhibit an increase in cell number rel-
ative to CD4 transgene negative littermates. This was observed even in CD4Tg1
Rag22/2 MHC class II1/1 progeny of MHC class II heterozygote crosses. This is
likely due to nonspecific changes in genetic background. (B) Scatter graph of the
percentage of CD41CD81 thymocytes from the progeny of CD4Tg1 Rag22/2 3
MHC class II2/2 matings. Each circle shows a data point from an individual
mouse, with the mean represented by a bold plus sign (1). The number of mice
analyzed for each type is indicated across the top of the graph. CD4 transgene
negative littermate controls (LMC) included MHC class II null, heterozygous
and wild-type mice.126 CD4 Behaves as an MHC Class II-responsive Signaling Element
ascribed to the presence of the neomycin phosphotrans-
ferase cassette within the closely integrated CD3gde gene
cluster (11). Despite high-level expression of the CD4
transgene in CD3e2/2 thymocytes, no appreciable induc-
tion of maturation was observed (Fig. 5). We conclude that
although CD4 expression can substitute for the TCR-b
chain in promoting thymocyte development, this effect re-
quires expression of CD3 polypeptides.
Discussion
Experiments in genetically manipulated mice support a
generally accepted model for pre-TCR function in which
productive rearrangement of a TCR-b chain in immature
DN thymocytes leads to formation of a functional pre-
TCR complex composed of the TCR-b chain, the non-
polymorphic pTa-chain, and CD3 signaling molecules.
Formation of the pre-TCR complex subsequently results
Figure 4. Flow cytometric
analysis of thymocytes from con-
trol and CD4Tg1 Rag22/2 MHC
class II2/2 littermates treated
with anti-CD3e or anti-CD4
mAb. (A) 4-wk-old mice were
treated intraperitoneally with 100
mg of the anti-CD3e mAb 2C11
(top panels), or 20 mg of the anti-
CD4 mAb GK1.5 (bottom panels).
After 4 d, thymocytes were
stained and analyzed by flow cy-
tometry using anti-CD4-PE and
anti-CD8-FITC. Identical results
were obtained for CD4Tg1
Rag22/2 MHC II2/2 mice
treated with 100 mg or 500 mg
GK1.5. The percentage of cells
in each population is indicated.
Total thymocyte numbers were
as follows: anti-CD3e–treated
Rag22/2 MHC II2/2 (1.2 3 107)
or CD4 Rag22/2 MHC II2/2
mice (3.2 3 107). (B) Single pa-
rameter fluorescence histograms
show CD69 expression 20 h af-
ter treatment with 150 mg of
mAb 2C11 (gray line) or GK1.5
(thick black line) as compared to
untreated controls (thin black
line).127 Norment et al.
in the activation of p56lck, leading to both proliferation and
maturation to the DP stage of thymocyte development (6,
10, 37). As Lck is a pivotal component of the TCR signal-
ing apparatus (19), it might be expected to function simi-
larly in pre-TCR and mature TCR signaling.
Animals lacking either of the recombinase activating
genes (Rag1 and Rag2) have provided a convenient exper-
imental platform for identifying signaling components that
regulate early thymocyte maturation (26, 38). For example,
the introduction of transgenes encoding a functional TCR-b
chain, or an activated version of p56lck (7, 17), into Rag2/2
mice stimulates maturation of DN thymocytes. In addition,
some functional pre-TCR components are expressed at the
cell surface on Rag2/2 thymocytes, because treatment of
these cells with anti-CD3e can induce both thymocyte
proliferation and differentiation (35) in an Lck-dependent
manner. However, CD3e treatment almost certainly acti-
vates several signaling pathways, including some that may
not involve p56lck. Interestingly, a chimeric transgene en-
coding an IL-2 receptor a chain (CD25) extracellular do-
main linked to intracellular sequences derived from CD3e
or the z chain can also stimulate pre-T cell development
when cross-linked with anti-CD25 antibodies in vivo (39).
This experiment, analogous to those performed using cul-
tured T cell lines, further reinforces the view that pre-
TCR signal transduction involves similar biochemical
mechanisms to those that mediate TCR signaling in ma-
ture T cells.
By expressing CD4 in the DN thymocytes of Rag22/2
mice, we sought to develop a system wherein a defined,
extracellularly-imposed signal would stimulate thymocyte
maturation through activation of p56lck. The remarkable
changes provoked by CD4 expression—an increase in cell
number, activation of the CD8 gene, extinction of CD25
synthesis, and a decrease in cell size—mimic those changes
imposed after pre-TCR stimulation. Propagation of these
effects requires sequences in the CD4 cytoplasmic domain
known to couple CD4 to p56lck, as well as the expression
of MHC class II molecules and CD3 proteins. As murine
T-lineage progenitors do not themselves express significant
levels of MHC class II molecules (33, 34), these results
demonstrate that CD4 can couple to endogenous Lck in
such a way that interaction with an extracellular ligand, in
this case class II molecules, stimulates changes in gene ex-
pression.
Numerous previous studies have documented the ability
of the CD4 coreceptor to behave as a ligand for MHC
class II molecules and to augment the response of class II–
restricted T cells to appropriate antigen-presenting cells.
Though the ability of CD4 to associate physically with Lck
(18) and to stimulate Lck activity when experimentally oli-
gomerized (21, 22) has long been recognized, the mecha-
nism by which CD4 functions in cell signaling remains un-
clear. For example, in T cell hybridomas known to require
CD4 for antigen recognition, a chimeric CD4 protein co-
valently linked to a catalytically inactive Lck molecule
proved equipotent to wild-type CD4 (40). This result was
observed even when the kinase domain of Lck was deleted
entirely. Similarly, a tailless CD4 transgene (a construct
identical to the CD4D construct which we have employed)
was capable of directing substantial maturation of class II–
restricted cells from the DP to the SP stage (41). These ob-
servations prompted the development of models in which
Lck might act to regulate CD4 adhesion in a kinase-inde-
pendent manner, rather than to deliver CD4-derived sig-
nals through tyrosine phosphate transfer (19).
Our experiments show that CD4, by binding class II,
can stimulate an Lck-dependent process. Prior studies re-
veal that disruption of the lck gene substantially blocks
thymocyte development at the DN to DP transition (14).
Moreover, high level expression of a catalytically inactive
version of Lck can completely block thymocyte develop-
ment at the DN stage (13). These experiments demonstrate
that the catalytic activity of Lck is required for satisfactory
thymocyte maturation, a conclusion supported by the abil-
ity of activated Lck to stimulate the same maturational
events (17). In a sense, the DN to DP transition serves as an
extremely sensitive in vivo bioassay for Lck function,
which permitted us to demonstrate that the binding of
CD4 to class II molecules can stimulate signal transduction.
This result in turn may serve to explain why z ITAM mo-
tifs are constitutively phosphorylated in wild-type DP thy-
mocytes (42): the binding of class II to CD4 triggers an in-
crease in Lck kinase activity, resulting in phosphorylation
of antigen receptor components. By inference, the pres-
ence of a constitutive Lck-activating stimulus can therefore
be considered a normal feature of cortical thymic environ-
ments.
Efficiency of CD4 Transgene-driven Thymocyte Maturation
and Proliferation. An activated p56lck transgene stimulates
thymocyte development in Rag12/2 mice (17), and aug-
mented expression of wild-type p56lck triggers allelic exclu-
sion at the TCR b-chain locus (43). The results presented
here show that activation of endogenous Lck, using a trans-
genic wild-type CD4 molecule as a signal sensor, promotes
the DN to DP transition. These observations are consistent
Figure 5. Flow cytometric analysis of thymocytes from CD3e2/2 (left
panel) or CD4 transgene-bearing CD3e2/2 (right panel) littermates. The
percentage of cells in each population is indicated.128 CD4 Behaves as an MHC Class II-responsive Signaling Element
with experiments demonstrating that ionizing radiation
(known to activate src-family PTKs) promotes thymocyte
development in an lck-dependent manner (44).
However, the CD4 transgene induced only a modest in-
crease in total thymocyte number in Rag22/2 mice, much
less than that observed when a TCR-b (17) or activated lck
transgene (17) is used. This difference suggests that CD4
behaves less efficiently on a per cell basis in promoting the
DN to DP transition. Alternatively CD4 may deliver a
qualitatively different signal to developing thymocytes than
does the normal pre-TCR complex. Using anti-CD4 mAb
treatment, we observed that all DN, transgene-bearing thy-
mocytes can respond to CD4-derived signals, as judged by
CD69 induction (Fig. 4 B). However, inasmuch as even a
50% reduction in class II expression dramatically decreases
the efficiency of CD4-stimulated thymocyte maturation
(Fig. 3), satisfactory stimulation of the DN to DP transition
by transgenic CD4 appears to be exquisitely sensitive to the
presence of an appropriate ligand. This limiting effect of
class II abundance suggests that the CD4-derived signal
may differ only quantitatively from that which is entrained
by pre-TCR stimulation. As thymocytes are thought to
undergo at least seven rounds of replication in developing
from the DN to the DP stage (13, 45), CD4 transgene-
mediated activation of a small number of pre-T cells could
produce thymi in which the majority of cells exhibit a
more mature phenotype, without greatly increasing the to-
tal number of thymocytes. We cannot, however, exclude
the possibility that CD4-derived signals differ qualitatively
from pre-TCR signals, perhaps by activating only a subset
of Lck-dependent signal transduction cascades.
Must p56lck Interact with Pre-TCR Components to Drive De-
velopment? Unlike Rag22/2 mice, expression of the CD4
transgene in CD3e2/2 mice failed to induce thymocyte de-
velopment (Fig. 5). These results echo those obtained in
the Jurkat transformed T cell line, where coupling of p56lck
to CD3 signaling components is important for the trans-
mission of intracellular signals (46). Viewed from one per-
spective, the inability of the CD4/Lck signal to mediate
development in the absence of CD3 indicates that the CD3
components function downstream of Lck, especially be-
cause CD3 ITAM motifs are good substrates for the Lck
kinase (47). However it remains equally plausible that
CD4/Lck complexes must colocalize with the pre-TCR as
a means of approximating Lck with another positive regu-
lator, e.g., CD45. Prior studies implicate the CD45 phos-
phatase in the dephosphorylation of a negative regulatory
site (tyrosine 505) in Lck (48).
Although we cannot yet identify the targets of Lck-
mediated catalysis, it seems certain that simple activation of
the Lck kinase cannot serve by itself to stimulate thymocyte
development. We conclude that Lck must be juxtaposed
with its intracellular targets to permit satisfactory signal
transduction. The localization of these proteins therefore
could serve as another means of regulating thymocyte mat-
uration.
Finally, it bears mention that the expression of CD4 var-
ies in a peculiar and characteristic way during thymocyte
maturation. Very immature hematopoietic progenitors ex-
press CD4, which disappears shortly after arrival in the
thymus (49). CD4 reappears in all thymocytes after pre-
TCR-mediated stimulation, and then is extinguished in
cells that express class I–restricted receptors. Suppression of
CD4 transcription requires the activity of a dedicated si-
lencer, a conserved cis-acting element (50). Because CD4
expression can, as we demonstrate, drive thymocyte matu-
ration even in the absence of TCR-b chain expression, our
results suggest that extinction of CD4 expression in very
immature thymocytes is required to permit proper sensing
of TCR-b chain gene assembly, and the consequent regu-
lation of thymocyte maturation.
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